Literature DB >> 25922807

Selective immunoglobulin a deficiency in type 1 diabetes mellitus: a prevalence study in Western sicily (Italy).

Domenico Greco1, Filippo Maggio1.   

Abstract

BACKGROUND: The association between type 1 diabetes and immunoglobulin A deficiency (IgA-D) has long been recognized in many populations. The aim of this study was to assess the prevalence of IgA-D in patients with type 1 diabetes mellitus all coming from a defined geographical area and to investigate the clinical features of these subjects.
METHODS: The records of 150 consecutive patients with type 1 diabetes mellitus referred in a period of one year were analyzed. A detailed history was obtained for each patient. Information was collected concerning age, gender, time of onset of diabetes, and presence of other autoimmune diseases.
RESULTS: Out of 150 patients with type 1 diabetes, eight (5.3%) had a diagnosis of IgA-D. There were one female and seven male; all these patients were diagnosed by screening: none of them had history of recurrent infections. Autoimmune thyroiditis was coexisting in five patients (62%). Although other associated autoimmune disorders were found in a number of patients, there was no different prevalence rate in IgA deficient patients.
CONCLUSION: This study shows the prevalence of IgA-D in Sicilian patients with type 1 diabetes as 5.3% which is much higher than reported in other Italian studies. Moreover, our data show a high prevalence of IgA-D in male gender and describe thyroiditis as the most frequent autoimmune disease present in these patients. Finally, in our case report, IgA-D diagnosis always followed routine IgA measurement when case finding for celiac disease with no history of recurrent infections in each patient.

Entities:  

Keywords:  Diabetes mellitus, type 1; IgA deficiency; Prevalence

Year:  2015        PMID: 25922807      PMCID: PMC4411544          DOI: 10.4093/dmj.2015.39.2.132

Source DB:  PubMed          Journal:  Diabetes Metab J        ISSN: 2233-6079            Impact factor:   5.376


  28 in total

1.  Precocious and exaggerated seric IgA production in children affected by IDDM.

Authors:  N Gasparini; G Valerio; A Argenziano; M Salerno; G De Filippo; A Franzese; A Tenore
Journal:  Diabetes Care       Date:  1996-07       Impact factor: 19.112

Review 2.  Selective IgA deficiency in autoimmune diseases.

Authors:  Ning Wang; Nan Shen; Timothy J Vyse; Vidya Anand; Iva Gunnarson; Gunnar Sturfelt; Solbritt Rantapää-Dahlqvist; Kerstin Elvin; Lennart Truedsson; Bengt A Andersson; Charlotte Dahle; Eva Ortqvist; Peter K Gregersen; Timothy W Behrens; Lennart Hammarström
Journal:  Mol Med       Date:  2011-08-04       Impact factor: 6.354

3.  Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus.

Authors:  O Kordonouri; W Dieterich; D Schuppan; G Webert; C Müller; N Sarioglu; M Becker; T Danne
Journal:  Diabet Med       Date:  2000-06       Impact factor: 4.359

4.  Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten-free diet.

Authors:  C L Acerini; M L Ahmed; K M Ross; P B Sullivan; G Bird; D B Dunger
Journal:  Diabet Med       Date:  1998-01       Impact factor: 4.359

5.  Evaluation of serum IgA levels in Iranian patients with type 1 diabetes mellitus.

Authors:  Fatemeh Sayarifard; Asghar Aghamohammadi; Mohammad Taghi Haghi-Ashtiani; Asadollah Rajab; Heshmat Irani; Javad H Ahmadian; Ahya Zaridoost; Nima Parvaneh; Nima Rezaei; Ali Rabbani
Journal:  Acta Diabetol       Date:  2010-04-22       Impact factor: 4.280

6.  Primary immunodeficiencies: 2009 update.

Authors:  Luigi D Notarangelo; Alain Fischer; Raif S Geha; Jean-Laurent Casanova; Helen Chapel; Mary Ellen Conley; Charlotte Cunningham-Rundles; Amos Etzioni; Lennart Hammartröm; Shigeaki Nonoyama; Hans D Ochs; Jennifer Puck; Chaim Roifman; Reinhard Seger; Josiah Wedgwood
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 7.  Endocrinological disorders and celiac disease.

Authors:  Pekka Collin; Katri Kaukinen; Matti Välimäki; Jorma Salmi
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

8.  Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes.

Authors:  K A Fraser-Reynolds; J D Butzner; D K Stephure; R A Trussell; R B Scott
Journal:  Diabetes Care       Date:  1998-11       Impact factor: 19.112

9.  Immunoglobulin levels, immunodeficiency and HLA in type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Hoddinott; J Dornan; J C Bear; N R Farid
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

Review 10.  Selective IgA deficiency.

Authors:  Leman Yel
Journal:  J Clin Immunol       Date:  2010-01-26       Impact factor: 8.317

View more
  2 in total

1.  Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes.

Authors:  Patrick Hanley; Jennifer A Sutter; Noah G Goodman; Yangzhu Du; Debora R Sekiguchi; Wenzhao Meng; Michael R Rickels; Ali Naji; Eline T Luning Prak
Journal:  Clin Immunol       Date:  2017-09-23       Impact factor: 3.969

2.  Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune Disease.

Authors:  Jing W Hughes; Yicheng K Bao; Maamoun Salam; Prajesh Joshi; C Rachel Kilpatrick; Kavita Juneja; David Nieves; Victoria Bouhairie; Olivia J Jordan; Erica C Blustein; Garry S Tobin; Janet B McGill
Journal:  Diabetes Care       Date:  2018-10-25       Impact factor: 19.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.